Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
9.62M
-
Shares change
-
+44.4K
-
Total reported value, excl. options
-
$829M
-
Value change
-
-$306K
-
Put/Call ratio
-
1.69
-
Number of buys
-
55
-
Number of sells
-
-43
-
Price
-
$86.22
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q3 2019
138 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q3 2019.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.62M shares
of 22.2M outstanding shares and own 43.32% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1.68M shares), BAKER BROS. ADVISORS LP (1.17M shares), HealthCor Management, L.P. (1.03M shares), WELLINGTON MANAGEMENT GROUP LLP (842K shares), VANGUARD GROUP INC (790K shares), BlackRock Inc. (578K shares), STATE STREET CORP (502K shares), Avoro Capital Advisors LLC (360K shares), ALLIANCEBERNSTEIN L.P. (330K shares), and JENNISON ASSOCIATES LLC (276K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.